Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase 1 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with glioblastoma or non-small-cell lung cancer.
- Authors
- Johnson, Melissa Lynne; Henry, Jason Timothy; Spira, Alexander I.; Battiste, James; Alnahhas, Iyad; Ahluwalia, Manmeet Singh; Barve, Minal A.; Edenfield, William Jeffery; Nam, Do-Hyun; Eathiraj, Sudharshan; Hajdenberg, Julio; Yurasov, Sergey; Yu, Helena Alexandra; Wen, Patrick Y.
- Issue Date
- May-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
1527-7755
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.